The State of Cancer Care in America, 2016: A Report by the American Society of Clinical Oncology
Open accessThe DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
Medicare & Medicaid Innovation (CMMI) and private payers as they seek better ways to incentivize and support high-quality, high-value patient care.• Congress should aggressively monitor implementation of MACRA to ensure (1) that the Administration works with professional organizations to test multiple payment models of care and (2) the Administration provides a clear path for implementation of payment models shown to provide positive results for patients, providers, and payers.Advance health information technology that supports efficient, coordinated care across the cancer care continuum.• Congress should require that health information technology vendors create products that promote interoperability.• Policymakers should ensure that patients with cancer, oncologists, and other oncology providers do not bear the cost of achieving interoperable EHRs and that companies refrain from information blocking.• Professional organizations and other stakeholders should work with federal officials to ensure that health care providers have the information necessary to be prudent purchasers and users of health information technology systems.Recognize and address the unsustainable trend in the cost of cancer care.• Congress should work with stakeholders to pursue solutions that will curb unsustainable costs for patients, providers, and the health care system.• Payers should design payment systems that incentivize patient-centered, high-value care and invest in infrastructure that supports a viable care delivery system.• Professional organizations should develop and disseminate clinical guidelines, tools, and resources such as Choosing Wisely to optimize patient care, reduce waste, and avoid inappropriate treatment.• Professional organizations should promote shared decision making between patients and physicians and the development of high-value treatment plans consistent with patients' needs, values, and preferences.ASCO will continue to: (1) track and evaluate the evershifting landscape in cancer care over the coming year, (2) support cancer care providers as they negotiate these growing pressures, and (3) work with policymakers to ensure that changes in the system support access to high-quality, highvalue care for all patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nivolumab versus docetaxel in advanced nonsquamous non-small-cell lung cancer
Borghaei, H., Paz-Ares, L., Horn, L., Spigel, D. R., Steins, M., Ready, N. E., Chow, L. Q., Vokes, E. E., Felip, E., Holgado, E., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1507643 · Cited by 9,335 · cited 1×
“In 2015, nivolumab and pembrolizumab both received FDA approval for treatment of non–small-cell lung cancer based on compelling clinical research findings.(1,27) Other clinical trials have shown notable benefits for patients with liver cancer, head and neck cancer, stomach cancer, bladder cancer, and Hodgkin lymphoma.”
BackgroundCombined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma
Larkin, J., Chiarion-Sileni, V., Gonzalez, R., Grob, J. J., Cowey, C. L., Lao, C. D., Schadendorf, D., Dummer, R., Smylie, M., Rutkowski, P., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1504030 · Cited by 8,157
Rahib, L., Smith, B. D., Aizenberg, R., Rosenzweig, A. B., Fleshman, J. M., & Matrisian, L. M. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-0155 · Cited by 7,094
Nivolumab and ipilimumab versus ipilimumab in untreated melanoma
Postow, M. A., Chesney, J., Pavlick, A. C., Robert, C., Grossmann, K., McDermott, D., Linette, G. P., Meyer, N., Giguere, J. K., Agarwala, S. S., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1414428 · Cited by 2,781
Ramsey, S., Blough, D., Kirchhoff, A., Kreizenbeck, K., Fedorenko, C., Snell, K., Newcomb, P., Hollingworth, W., & Overstreet, K. (2013) · Health Affairs · doi:10.1377/hlthaff.2012.1263 · Cited by 699
Newcomer, L. N., Gould, B., Page, R. D., Donelan, S. A., & Perkins, M. (2014) · Journal of Oncology Practice · doi:10.1200/jop.2014.001488 · Cited by 128
Community Oncology Medical Homes: Physician-Driven Change to Improve Patient Care and Reduce Costs
Waters, T. M., Webster, J. A., Stevens, L. A., Li, T., Kaplan, C. M., Graetz, I., & McAneny, B. L. (2015) · Journal of Oncology Practice · doi:10.1200/jop.2015.005256 · Cited by 47
Cited by
Financial Hardships Experienced by Cancer Survivors: A Systematic Review
Altice, C. K., Banegas, M. P., Tucker-Seeley, R. D., & Yabroff, K. R. (2017) · Journal of the National Cancer Institute · doi:10.1093/jnci/djw205 · Cited by 864
Digital health for optimal supportive care in oncology: benefits, limits, and future perspectives
Aapro, M., Bossi, P., Dasari, A., Fallowfield, L., Gascón, P., Geller, M., Jordan, K., Kim, J., Martin, K., & Porzig, S. (2020) · Supportive Care in Cancer · doi:10.1007/s00520-020-05539-1 · Cited by 311
The state of Cancer Care in America, 2017: a report by the American Society of Clinical Oncology
The American Society of Clinical Oncology (2017) · Journal of Oncology Practice · doi:10.1200/jop.2016.020743 · Cited by 204
Informal caregiver burden for solid tumour cancer patients: a review and future directions
Thana, K., Lehto, R., Sikorskii, A., & Wyatt, G. (2021) · Psychology & Health · doi:10.1080/08870446.2020.1867136 · Cited by 97
Cho, H. L., Danis, M., & Grady, C. (2018) · Clinical Trials · doi:10.1177/1740774518792277 · Cited by 26
Metadata
- Authors
- American Society of Clinical Oncology
- Venue
- Journal of Oncology Practice
- Published
- 2016-04
- Volume
- 12
- Issue
- 4
- Pages
- 339-383
- ISSN
- 1554-7477 (ISSN-L)
- 1935-469X
- OpenAlex
- W4239502937
- Cited by
- 132
- References
- 7
- FWCI
- 49.01
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The State of Cancer Care in America, 2016: A Report by the American Society of Clinical Oncology. https://app.cochat.ai/papers/10.1200/jop.2015.010462
- The paper
- American Society of Clinical Oncology. (2016). The State of Cancer Care in America, 2016: A Report by the American Society of Clinical Oncology. Journal of Oncology Practice. https://doi.org/10.1200/jop.2015.010462
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.